Summit Therapeutics
SMMT
SMMT
203 hedge funds and large institutions have $1.65B invested in Summit Therapeutics in 2024 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 75 increasing their positions, 37 reducing their positions, and 26 closing their positions.
Holders
203
Holders Change
+37
Holders Change %
+22.29%
% of All Funds
2.7%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
67
Increased
75
Reduced
37
Closed
26
Calls
$36.7M
Puts
$53.9M
Net Calls
-$17.2M
Net Calls Change
+$2.43M
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$100M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$117M |
3 |
3
UBS Group
Zurich,
Switzerland
|
$21.2M |
4 |
4
Millennium Management
New York
|
$36.6M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$208M |